Advanced Bifurcation Systems

Advanced Bifurcation Systems is pioneering a transformative solution for coronary artery disease, specifically targeting bifurcation lesions where plaque blockages occur at vessel branches. With over 75 issued patents and FDA Breakthrough Device Designation, its proprietary platform enables precise, safe, and efficient stent placement, making advanced bifurcation stenting accessible to a broader range of interventional cardiologists. The company is positioned to address a significant unmet need in cardiovascular care, potentially reducing the need for open-heart surgery and optimizing hospital resource utilization.

A proprietary, modular dual-catheter stent delivery platform designed for the precise, simple, and safe treatment of coronary bifurcation lesions, featuring automatic alignment and guaranteed side-branch access without requiring new physician skills.

Competes against complex, off-label use of standard drug-eluting stents from giants like Abbott, Boston Scientific, and Medtronic, as well as historically unsuccessful dedicated bifurcation stents. ABS differentiates through its simple, fail-safe design that automates alignment, guarantees side-branch access, and requires no new physician skill set, backed by FDA Breakthrough Designation.